Skip to content

Clinical trials

Sexually Transmitted Diseases trials with no applicable phase and unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Sexually Transmitted Diseases Phase: Not applicable Status: Unknown status Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20041
20061
20091
20101
20122
20131
20151
20173
20194
20202
20211
20221
20235

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status26

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)2
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina2
National Development and Research Institutes, Inc.2
ANRS, Emerging Infectious Diseases1
Brown University1
French National Agency for Research on AIDS and Viral Hepatitis1
Fundació Institut Germans Trias i Pujol1
Liverpool School of Tropical Medicine1
London School of Hygiene and Tropical Medicine1
Lund University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Sexually Transmitted Diseases26
Acquired Immunodeficiency Syndrome5
HIV Infections4
Hepatitis3
Chlamydia Infections2
Gonorrhea2
Binge Drinking1
Blood-Borne Infections1
Communicable Diseases1
Hepatitis B1

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.